Toll-like receptors-2 and 4 are overexpressed in an experimental model of particle-induced osteolysis

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 9, 2014, Pages 3004-3011

  Valladares, Roberto D ^a   Nich, Christophe ^a,b,c   Zwingenberger, Stefan ^a,d   Li, Chenguang ^a   Swank, Katherine R ^a   Gibon, Emmanuel ^b   Rao, Allison J ^a   Yao, Zhenyu ^a   Goodman, Stuart B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Paris university   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

arthroplasty; immune response; murine calvarium; osteolysis; polyethylene; toll like receptor; ultra high molecular weight polyethylene; wear debris

Indexed keywords

ARTHROPLASTY; BONE; COMPUTERIZED TOMOGRAPHY; IMMUNE SYSTEM; INTERFERONS; MACROPHAGES;

IMMUNE RESPONSE; MURINE CALVARIUM; OSTEOLYSIS; TOLL-LIKE RECEPTORS; WEAR DEBRIS;

POLYETHYLENES;

POLYETHYLENE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; ULTRA HIGH MOLECULAR WEIGHT POLYETHYLENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE DENSITOMETRY; BONE DENSITY; BONE MASS; CALVARIA; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; JOINT PROSTHESIS; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PARTICLE INDUCED OSTEOLYSIS; PROSTHESIS FAILURE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; IMMUNOLOGY; PATHOLOGY; SKULL;

ANIMALS; MICE; MICE, INBRED C57BL; OSTEOCLASTS; OSTEOLYSIS; POLYETHYLENE; PROSTHESIS FAILURE; SKULL; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9;

EID: 84904806793     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34972     Document Type: Article

References (53)

1. Goodman SB, Wright T,. 2007 AAOS/NIH osteolysis and implant wear: Biological, biomedical engineering, and surgical principles. Introduction. J Am Acad Orthop Surg 2008; 16 (Suppl 1): x-xi.
2. Goodman SB,. Wear particles, periprosthetic osteolysis and the immune system. Biomaterials 2007; 28: 5044-5048.
3. Clohisy JC, Calvert G, Tull F, McDonald D, Maloney WJ,. Reasons for revision hip surgery: A retrospective review. Clin Orthop Relat Res 2004; 429: 188-192.
4. Lee K, Goodman SB,. Current state and future of joint replacements in the hip and knee. Expert Rev Med Devices 2008; 5: 383-393.
5. Thomas GER, Simpson DJ, Mehmood S, Taylor A, McLardy-Smith P, Gill HS, Murray DW, Glyn-Jones S,. The seven-year wear of highly cross-linked polyethylene in total hip arthroplasty: A double-blind, randomized controlled trial using radiostereometric analysis. J Bone Joint Surg Am 2011; 93: 716-722.
6. Al-Saffar N, Revell PA,. Differential expression of transforming growth factor-alpha and macrophage colony-stimulating factor/colony-stimulating factor-1R (c-fins) by multinucleated giant cells involved in pathological bone resorption at the site of orthopaedic implants. J Orthop Res 2000; 18: 800-807.
7. Greenfield EM, Bi Y, Ragab AA, Goldberg VM, Van De Motter RR,. The role of osteoclast differentiation in aseptic loosening. J Orthop Res 2002; 20: 1-8.
8. Ingham E, Fisher J,. The role of macrophages in osteolysis of total joint replacement. Biomaterials 2005; 26: 1271-1286.
9. Konttinen YT, Zhao D, Beklen A, Ma G, Takagi M, Kivela-Rajamaki M, Ashammakhi N, Santavirta S,. The microenvironment around total hip replacement prostheses. Clin Orthop Relat Res 2005; 430: 28-38.
10. Santavirta S, Takagi M, Gomez-Barrena E, Nevalainen J, Lassus J, Salo J, Konttinen YT,. Studies of host response to orthopedic implants and biomaterials. J Long Term Eff Med Implants 1999; 9: 67-76.
11. Goodman SB,. Does the immune system play a role in loosening and osteolysis of total joint replacements? J Long Term Eff Med Implants 1996; 6: 91-101.
12. Taki N, Tatro JM, Nalepka JL, Togawa D, Goldberg VM, Rimnac CM, Greenfield EM,. Polyethylene and titanium particles induce osteolysis by similar, lymphocyte-independent, mechanisms. J Orthop Res 2005; 23: 376-383.
13. Goodman S, Wang JS, Regula D, Aspenberg P,. T-lymphocytes are not necessary for particulate polyethylene-induced macrophage recruitment. Histologic studies of the rat tibia. Acta Orthop Scand 1994; 65: 157-160.
14. Uematsu S, Akira S,. Toll-like receptors and innate immunity. J Mol Med (Berl) 2006; 84: 712-725.
15. Takeda K, Akira S,. Toll-like receptors in innate immunity. Int Immunol 2005; 17: 1-14.
16. Arancibia SA, Beltran CJ, Aguirre IM, Silva P, Peralta AL, Malinarich F, Hermoso MA,. Toll-like receptors are key participants in innate immune responses. Biol Res 2007; 40: 97-112.
17. McCoy CE, O'Neill LA,. The role of toll-like receptors in macrophages. Front Biosci 2008; 13: 62-70.
18. Kawai T, Akira S,. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 2007; 13: 460-469.
19. Bar-Shavit Z,. Taking a toll on the bones: Regulation of bone metabolism by innate immune regulators. Autoimmunity 2008; 41: 195-203.
20. Tomchuck SL, Zwezdaryk KJ, Coffelt SB, Waterman RS, Danka ES, Scandurro AB,. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells 2008; 26: 99-107.
21. Nishiya T, DeFranco AL,. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors. J Biol Chem 2004; 279: 19008-19017.
22. Akira S, Takeda K, Kaisho T,. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675-680.
23. Janeway CA Jr, Medzhitov R,. Innate immune recognition. Annu Rev Immunol 2002; 20: 197-216.
24. Takeda K, Kaisho T, Akira S,. Toll-like receptors. Annu Rev Immunol 2003; 21: 335-376.
25. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S,. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740-745.
26. Vogel SN, Fenton M,. Toll-like receptor 4 signalling: New perspectives on a complex signal-transduction problem. Biochem Soc Trans 2003; 31 (Pt 3): 664-668.
27. Kawai T, Takeuchi O, Fujita T, Inoue J, Muhlradt PF, Sato S, Hoshino K, Akira S,. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 2001; 167: 5887-5894.
28. Serbina NV, Kuziel W, Flavell R, Akira S, Rollins B, Pamer EG,. Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection. Immunity 2003; 19: 891-901.
29. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S,. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003; 301: 640-643.
30. Pearl JI, Ma T, Irani AR, Huang Z, Robinson WH, Smith RL, Goodman SB,. Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles. Biomaterials 2011; 32: 5535-5542.
31. Sun DH, Trindade MC, Nakashima Y, Maloney WJ, Goodman SB, Schurman DJ, Smith RL,. Human serum opsonization of orthopedic biomaterial particles: Protein-binding and monocyte/macrophage activation in vitro. J Biomed Mater Res A 2003; 65: 290-298.
32. Goodman S, Aspenberg P, Song Y, Regula D, Lidgren L,. Polyethylene and titanium alloy particles reduce bone formation. Dose-dependence in bone harvest chamber experiments in rabbits. Acta Orthop Scand 1996; 67: 599-605.
33. Goodman SB, Ma T, Chiu R, Ramachandran R, Smith RL,. Effects of orthopaedic wear particles on osteoprogenitor cells. Biomaterials 2006; 27: 6096-6101.
34. Takagi M, Tamaki Y, Hasegawa H, Takakubo Y, Konttinen L, Tiainen VM, Lappalainen R, Konttinen YT, Salo J,. Toll-like receptors in the interface membrane around loosening total hip replacement implants. J Biomed Mater Res A 2007; 81: 1017-1026.
35. Grandjean-Laquerriere A, Tabary O, Jacquot J, Richard D, Frayssinet P, Guenounou M, Laurent-Maquin D, Laquerriere P, Gangloff S,. Involvement of toll-like receptor 4 in the inflammatory reaction induced by hydroxyapatite particles. Biomaterials 2007; 28: 400-404.
36. Maitra R, Clement CC, Crisi GM, Cobelli N, Santambrogio L,. Immunogenecity of modified alkane polymers is mediated through TLR1/2 activation. PLoS One 2008; 3: e2438.
37. Maitra R, Clement CC, Scharf B, Crisi GM, Chitta S, Paget D, Purdue PE, Cobelli N, Santambrogio L,. Endosomal damage and TLR2 mediated inflammasome activation by alkane particles in the generation of aseptic osteolysis. Mol Immunol 2009; 47: 175-184.
38. Hong-Geller E, Chaudhary A, Lauer S,. Targeting toll-like receptor signaling pathways for design of novel immune therapeutics. Curr Drug Discov Technol 2008; 5: 29-38.
39. Parkinson T,. The future of toll-like receptor therapeutics. Curr Opin Mol Ther 2008; 10: 21-31.
40. Campbell P, Ma S, Yeom B, McKellop H, Schmalzried TP, Amstutz HC,. Isolation of predominantly submicron-sized UHMWPE wear particles from periprosthetic tissues. J Biomed Mater Res 1995; 29: 127-131.
41. Xu Y, Hammerick KE, James AW, Carre AL, Leucht P, Giaccia AJ, Longaker MT,. Inhibition of histone deacetylase activity in reduced oxygen environment enhances the osteogenesis of mouse adipose-derived stromal cells. Tissue Eng Part A 2009; 15: 3697-3707.
42. Nich C, Rao AJ, Valladares RD, Li C, Christman JE, Antonios JK, Yao Z, Zwingenberger S, Petite H, Hamadouche M, Goodman SB,. Role of direct estrogen receptor signaling in wear particle-induced osteolysis. Biomaterials 2013; 34: 641-650.
43. Nich C, Takakubo Y, Pajarinen J, Ainola M, Salem A, Sillat T, Rao AJ, Raska M, Tamaki Y, Takagi M, Konttinen YT, Goodman SB, Gallo J,. Macrophages-key cells in the response to wear debris from joint replacements. J Biomed Mater Res A 2013; 101: 3033-3045.
44. Seibl R, Birchler T, Loeliger S, Hossle JP, Gay RE, Saurenmann T, Michel BA, Seger RA, Gay S, Lauener RP,. Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am J Pathol 2003; 162: 1221-1227.
45. Kim KW, Cho ML, Lee SH, Oh HJ, Kang CM, Ju JH, Min SY, Cho YG, Park SH, Kim HY,. Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation. Immunol Lett 2007; 110: 54-64.
46. Hausmann M, Kiessling S, Mestermann S, Webb G, Spottl T, Andus T, Scholmerich J, Herfarth H, Ray K, Falk W, Rogler G,. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 2002; 122: 1987-2000.
47. Beklen A, Hukkanen M, Richardson R, Konttinen YT,. Immunohistochemical localization of Toll-like receptors 1-10 in periodontitis. Oral Microbiol Immunol 2008; 23: 425-431.
48. Lucarelli M, Gatti AM, Savarino G, Quattroni P, Martinelli L, Monari E, Boraschi D,. Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles. Eur Cytokine Netw 2004; 15: 339-346.
49. Rao AJ, Zwingenberger S, Valladares R, Li C, Lane Smith R, Goodman SB, Nich C,. Direct subcutaneous injection of polyethylene particles over the murine calvaria results in dramatic osteolysis. Int Orthop 2013; 37: 1393-1398.
50. Ji JD, Park-Min KH, Shen Z, Fajardo RJ, Goldring SR, McHugh KP, Ivashkiv LB,. Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursors. J Immunol 2009; 183: 7223-7233.
51. McEvoy A, Jeyam M, Ferrier G, Evans CE, Andrew JG,. Synergistic effect of particles and cyclic pressure on cytokine production in human monocyte/macrophages: Proposed role in periprosthetic osteolysis. Bone 2002; 30: 171-177.
52. Ortiz SG, Ma T, Epstein NJ, Smith RL, Goodman SB,. Validation and quantification of an in vitro model of continuous infusion of submicron-sized particles. J Biomed Mater Res B Appl Biomater 2008; 84: 328-333.
53. Johnson AC, Heinzel FP, Diaconu E, Sun Y, Hise AG, Golenbock D, Lass JH, Pearlman E,. Activation of toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation. Invest Ophthalmol Vis Sci 2005; 46: 589-595.